Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Versus Graft Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01964625
What this trial is testing

Positron Emission Tomography - Computed Tomography (PET-CT) Scanning in Chronic Graft Versus Host Disease (cGvHD)

Who this might be right for
Chronic Graft Versus Host Disease
University of Rochester 1
Testing effectiveness (Phase 2)Ended earlyNCT02337517
What this trial is testing

Vismodegib in Treating Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft Versus Host Disease
National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)Study completedNCT02294552
What this trial is testing

Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaLymphoma+3 more
Ivan S Moiseev 200
Testing effectiveness (Phase 2)Study completedNCT00656058
What this trial is testing

Montelukast to Treat Bronchiolitis Obliterans

Who this might be right for
Bronchiolitis ObliteransChronic Graft Versus Host DiseaseLeukotriene+2 more
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Study completedNCT01557517
What this trial is testing

Clobetasol for Oral Graft-Versus-Host Disease

Who this might be right for
Oral Chronic Graft vs Host Disease
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT05305989
What this trial is testing

Extended Treatment and Follow-up of Subjects Treated With Belumosudil in Study KD025-208 or Study KD025-213

Who this might be right for
Chronic Graft-versus-host-disease
Kadmon, a Sanofi Company 23
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07643025
What this trial is testing

Belumosudil With Ruxolitnib as Second Line Therapy for Chronic Graft Versus Host Disease (cGvHD) After Steroid Failure

Who this might be right for
cGVHD
Dennis Kim 63
Testing effectiveness (Phase 2)WithdrawnNCT00002790
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT02712762
What this trial is testing

Ocular Surface Disease in Chronic Graft-Versus-Host Disease (GVHD) Patients

Who this might be right for
Dry EyeGVHD
Singapore National Eye Centre 5
Testing effectiveness (Phase 2)Ended earlyNCT04232397
What this trial is testing

Anlotinib Treatment in Steroid Depenent/Refractory cGVHD

Who this might be right for
Chronic Graft-versus-host-disease
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 5
Early research (Phase 1)Study completedNCT02318082
What this trial is testing

Study of Individual Adult and Pediatric Patient Dose-escalated Interleukin-2 Therapy for Refractory Chronic GVHD

Who this might be right for
Chronic Versus Graft Host Disease
Dana-Farber Cancer Institute 21
Testing effectiveness (Phase 2)Study completedNCT03298815
What this trial is testing

Study for the Treatment of Ocular Chronic Graft-Versus-Host Disease (GVHD) With Amniotic Fluid Eye Drops (AFED)

Who this might be right for
Ocular Graft Versus Host Disease
University of Utah 15
Testing effectiveness (Phase 2)Study completedNCT01246206
What this trial is testing

Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT

Who this might be right for
Hematological Malignancies
Barbara Ann Karmanos Cancer Institute 21
Testing effectiveness (Phase 2)Ended earlyNCT04640025
What this trial is testing

A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib

Who this might be right for
MyelofibrosisPostlung Transplant (Bronchiolitis Obliterans)Chronic Graft Versus Host Disease
Incyte Corporation 18
Testing effectiveness (Phase 2)Study completedNCT01244906
What this trial is testing

Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant

Who this might be right for
Hematologic Neoplasms
Northside Hospital, Inc. 26
Large-scale testing (Phase 3)Looking for participantsNCT06615050
What this trial is testing

Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 572
Not applicableLooking for participantsNCT07535008
What this trial is testing

Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft Versus Host DiseaseAcute Graft Versus Host DiseaseHematopoietic and Lymphatic System Neoplasm
Fred Hutchinson Cancer Center 45
Large-scale testing (Phase 3)Study completedNCT00438958
What this trial is testing

Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more
The Canadian Blood and Marrow Transplant Group 230
Early research (Phase 1)Study completedNCT01672229
What this trial is testing

Bortezomib in Patients With Chronic Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
Mehrdad Abedi, MD 16
Testing effectiveness (Phase 2)Study completedNCT05311514
What this trial is testing

Allogeneic Platelet Lysate Eye Drops for the Treatment of Severe Chronic Ocular Graft-versus-host Disease

Who this might be right for
Ocular Graft-versus-host Disease
St. Petersburg State Pavlov Medical University 38
Next Page